Results 11 to 20 of about 202,020 (287)

Intracerebral Hemorrhage [PDF]

, 2014
Intracerebral hemorrhage is an important clinical entity encountered in practice. Common causes of intracerebral hemorrhage include hypertension, amyloid angiopathy, trauma, coagulopathy, arteriovenous malformation and underlying tumor.
Corina Epple, Michael Brainin, Thorsten Steiner   +2 more
openaire   +2 more sources

Mitophagy in intracerebral hemorrhage: a new target for therapeutic intervention

Neural Regeneration Research
Intracerebral hemorrhage is a life-threatening condition with a high fatality rate and severe sequelae. However, there is currently no treatment available for intracerebral hemorrhage, unlike for other stroke subtypes.
Yiyang Chen, Wenxuan Tang, Xinqi Huang, Yumei An, Jiawen Li, Shengye Yuan, Haiyan Shan, Mingyang Zhang   +7 more
doaj   +2 more sources

Intracerebral Hemorrhage with Churg Strauss-Syndrome: Multidisciplinary Collaboration and Literature Review [PDF]

Vascular Health and Risk Management
Pu Bai,* Peitao Xie* Inner Mongolia Medical University Ordos School of Clinical Medicine, Ordos, 017000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Pu Bai; Peitao Xie, Ordos Center Hospital, No. 6
Bai P, Xie P
doaj   +1 more source

Intracerebral hemorrhage [PDF]

Neurosciences, 2009
OBJECTIVE: To study intracerebral hemorrhage (ICH) at Jordan University Hospital (JUH) with the aim of assessing prevalence, age/gender distribution, causes, clinical manifestations, and location of ICH on CT brain, treatment modalities and outcome, and to compare these findings with those from Middle Eastern and Western literature. METHODS: Among 1498
openaire   +4 more sources

Intracerebral Hemorrhage Genetics

Genes, 2022
Intracerebral hemorrhage (ICH) is a devastating type of stroke, frequently resulting in unfavorable functional outcomes. Up to 15% of stroke patients experience ICH and approximately half of those have a lethal outcome within a year. Considering the huge burden of ICH, timely prevention and optimized treatment strategies are particularly relevant ...
Aleksandra Ekkert, Aleksandra Šliachtenko, Algirdas Utkus, Dalius Jatužis   +3 more
openaire   +2 more sources

Neuroimaging in Intracerebral Hemorrhage [PDF]

Stroke, 2014
Intracerebral hemorrhage (ICH) is described as spontaneous extravasation of blood into the brain parenchyma. This clinical entity is present in 10% to 15% of all stroke cases1 in the Western population, with reported incidence rates higher in Asia.2–4 It is also associated with a higher mortality rate compared with either ischemic stroke (IS) or ...
Macellari F, PACIARONI, Maurizio, AGNELLI, Giancarlo, CASO, Valeria   +3 more
openaire   +3 more sources

Prediction of intracerebral hemorrhage in patients with out-of-hospital cardiac arrest using post-resuscitation electrocardiogram: An observational cohort study

Resuscitation Plus, 2022
Aim: We evaluated the characteristics of patients with intracerebral hemorrhage in nontraumatic out-of-hospital cardiac arrests (OHCA) after return of spontaneous circulation (ROSC) to identify patients who required brain computed tomography as the next ...
Ryota Kaichi, Masanobu Ishii, Kyohei Marume, Masafumi Takae, Takayuki Mori, Soichi Komaki, Reiko Toida, Kazumasa Kurogi, Yasuhiro Nagamine, Shigeyuki Nishikawa, Masakazu Matsuyama, Tetsuro Yamaguchi, Takao Yano, Kenichi Tsujita, Nobuyasu Yamamoto   +14 more
doaj   +1 more source

CARDIAC TROPONIN T: AN INDICATOR OF SEVERITY IN PATIENTS WITH PRIMARY INTRACERBERAL HEMORRHAGE [PDF]

Zagazig University Medical Journal, 2023
Background: primary intracerebral hemorrhage is one of the most common forms of stroke producing major disability. Cardiac troponin T is used as an indicator of severity in patients with primary intracerebral hemorrhage.
Mohammed Aly Ghonemy, Wael Elsayed, Mahmoud Alebiary, Arwa Ragab   +3 more
doaj   +1 more source

Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studies [PDF]

, 2005
<p><b>Background and Purpose:</b> Glycine Antagonist in Neuroprotection (GAIN) International and GAIN Americas trials were prospectively designed, randomized, placebo-controlled trials of gavestinel, a glycine-site antagonist and ...
Lees, K.R., Brown, D.L., Levin, B., Pittman, J.G., Ordronneau, P., Sacco, R.L., Davis, S., Derosa, J.T., Thompson, J.L.P., Haley, E.C., ORDRONNEAU P, DEROSA J. T, CLARKE HALEY, E. JR, LEVIN, Bruce, THOMPSON J. L. P, PITTMAN J. C, DAVIS, Stephen, LEES, K. L, BROWN, D. L, FOR THE GAIN AMERICAS AND GAIN, DAVIS S, CAROLEI, ANTONIO, PITTMAN, John G, DEROSA, Janet T, ORDRONNEAU, Paul, SACCO R. L, INTERNATIONAL INVESTIGATORS, LEVIN B, HALEY E. C, SACCO, Ralph L, THOMPSON, John L. P, LEES, Kennedy R, BROWN, Devin L   +32 more
core   +1 more source

Fahr’s Disease With Intracerebral Hemorrhage at the Uncommon Location: A Case Report [PDF]

Annals of Rehabilitation Medicine, 2019
Fahr’s disease (FD) is a rare neurologic disorder characterized by the symmetric and bilateral intracerebral calcification in a patient. We describe the case of a 65-year-old woman who presented with gait disturbance, abnormal mentality, and visual field
Baek Hee Jang, Seong Wook Son, Chung Reen Kim   +2 more
doaj   +1 more source